Gentex Corp (GNTX) concluded trading on Thursday at a closing price of $23.88, with 3.04 million shares of worth about $72.69 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -22.72% during that period and on March 27, 2025 the price saw a loss of about -3.55%. Currently the company’s common shares owned by public are about 227.21M shares, out of which, 226.28M shares are available for trading.
Stock saw a price change of -0.87% in past 5 days and over the past one month there was a price change of -2.61%. Year-to-date (YTD), GNTX shares are showing a performance of -16.88% which decreased to -33.48% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $23.50 but also hit the highest price of $36.46 during that period. The average intraday trading volume for Gentex Corp shares is 2.05 million. The stock is currently trading -2.23% below its 20-day simple moving average (SMA20), while that difference is down -5.78% for SMA50 and it goes to -18.58% lower than SMA200.
Gentex Corp (NASDAQ: GNTX) currently have 227.21M outstanding shares and institutions hold larger chunk of about 96.55% of that.
The stock has a current market capitalization of $5.43B and its 3Y-monthly beta is at 0.82. PE ratio of stock for trailing 12 months is 13.61, while it has posted earnings per share of $1.75 in the same period. Its PEG reads 1.21 and has Quick Ratio of 2.38 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GNTX, volatility over the week remained 2.33% while standing at 2.48% over the month.
Stock’s fiscal year EPS is expected to rise by 7.32% while it is estimated to increase by 13.90% in next year. EPS is likely to grow at an annualized rate of 11.29% for next 5-years, compared to annual growth of 1.27% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by UBS on September 04, 2024 offering a Neutral rating for the stock and assigned a target price of $34 to it. Coverage by Exane BNP Paribas stated Gentex Corp (GNTX) stock as a Neutral in their note to investors on July 30, 2024, suggesting a price target of $34 for the stock. On July 06, 2023, BofA Securities Upgrade their recommendations, while on December 14, 2022, Goldman Upgrade their ratings for the stock with a price target of $26. Stock get an Outperform rating from Exane BNP Paribas on April 11, 2022.